Literature DB >> 1873694

Morphometric evidence for bone resorption and replacement in prostate cancer.

N W Clarke1, J McClure, N J George.   

Abstract

A series of 78 patients with metastatic bone disease from prostate cancer underwent iliac crest biopsy, enabling histomorphometric quantification of eroded bone surface and bone volume in both tumour-free and metastatic bone tissue. Eroded surfaces in tumour-free specimens were high in patients with active compared to stable disease but bone volume was maintained in both groups, whilst in bone surrounding micrometastases (n = 8) eroded surfaces were further increased and bone volume reduced. Eroded surfaces within metastases were greater still but were associated with increased bone volume due to replacement of the existing trabecular tissue with abnormal woven bone, giving an overall appearance of sclerosis. These results show that the effect of prostate cancer on bone tissue is complex, involving differential disturbance of bone formation and resorption within metastases, in bone surrounding tumour invasion and in the tumour-free skeleton.

Entities:  

Mesh:

Year:  1991        PMID: 1873694     DOI: 10.1111/j.1464-410x.1991.tb15260.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  33 in total

1.  Bisphosphonates in metastatic prostate cancer.

Authors:  Masood A Khan; Alan W Partin
Journal:  Rev Urol       Date:  2003

2.  Histopathological assessment of prostate cancer bone osteoblastic metastases.

Authors:  Martine P Roudier; Colm Morrissey; Lawrence D True; Celestia S Higano; Robert L Vessella; Susan M Ott
Journal:  J Urol       Date:  2008-07-18       Impact factor: 7.450

Review 3.  Treatment and prevention of bone complications from prostate cancer.

Authors:  Richard J Lee; Philip J Saylor; Matthew R Smith
Journal:  Bone       Date:  2010-05-31       Impact factor: 4.398

4.  BMP4 promotes prostate tumor growth in bone through osteogenesis.

Authors:  Yu-Chen Lee; Chien-Jui Cheng; Mehmet A Bilen; Jing-Fang Lu; Robert L Satcher; Li-Yuan Yu-Lee; Gary E Gallick; Sankar N Maity; Sue-Hwa Lin
Journal:  Cancer Res       Date:  2011-06-13       Impact factor: 12.701

5.  Three-dimensional trabecular bone architecture of the lumbar spine in bone metastasis from prostate cancer: comparison with degenerative sclerosis.

Authors:  Tsutomu Tamada; Teruki Sone; Yoshimasa Jo; Shigeki Imai; Yasumasa Kajihara; Masao Fukunaga
Journal:  Skeletal Radiol       Date:  2004-11-16       Impact factor: 2.199

Review 6.  Strategies for management of prostate cancer-related bone pain.

Authors:  R C Pelger; V Soerdjbalie-Maikoe; N A Hamdy
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 7.  Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons.

Authors:  Laura Evangelista; Francesco Bertoldo; Francesco Boccardo; Giario Conti; Ilario Menchi; Francesco Mungai; Umberto Ricardi; Emilio Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-09       Impact factor: 9.236

Review 8.  Molecular mechanisms of metastasis in prostate cancer.

Authors:  Noel W Clarke; Claire A Hart; Mick D Brown
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

Review 9.  RANKL/RANK/OPG: key therapeutic target in bone oncology.

Authors:  Kosei Ando; Kanji Mori; Francoise Rédini; Dominique Heymann
Journal:  Curr Drug Discov Technol       Date:  2008-09

10.  Analgesic efficacy of zoledronic acid and its effect on functional status of prostate cancer patients with metastasis.

Authors:  Rafael Gálvez; Victoria Ribera; José Ramón González-Escalada; Alicia Souto; María Luz Cánovas; Andrés Castro; Begoña Herrero; María de Los Angeles Maqueda; Matilde Castilforte; José Javier Marco-Martínez; Concepción Pérez; Lorenza Vicente-Fatela; Consuelo Nieto Md; Maria José Orduña; Anna Padrol; Enrique Reig; Joaquín Carballido; José Manuel Cózar
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.